As is well known, laboratory tests that are routinely included in the evaluation of patients with suspected NAFLD include a serum panel of liver tests (alanine aminotransferase (ALT), aspartate aminotransferase, alkaline phosphatase, and gamma-glutamyl-transpeptidase). Here, GGTLC1 is linked to metabolic dysfunction-associated steatotic liver disease.